FdaApplication
NDA 219469
Identifiers
- fda_app_no: NDA219469
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2025-10-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYNKUET | ELINZANETANT | 60MG | CAPSULE;ORAL |
1 product